Stroke in Children with Sickle Cell Disease - PubMed (original) (raw)
Stroke in Children with Sickle Cell Disease
Fenella J. Kirkham et al. Curr Treat Options Neurol. 2004 Sep.
Abstract
Children with sickle disease are at high risk for ischemic stroke and transient ischemic attacks, usually secondary to intracranial arteriopathy involving the terminal internal carotid and proximal middle cerebral and anterior cerebral arteries, which may be diagnosed using transcranial Doppler ultrasound or magnetic resonance angiography (MRA). Other central nervous system (CNS) complications include seizures and coma, which may be secondary to ischemic stroke, sinovenous thrombosis, reversible posterior leukoencephalopathy, or acute demyelination. The immediate priority after an acute CNS event is to improve cerebral oxygenation with oxygen supplementation to maintain peripheral saturation measured using pulse oximetry between 96% and 99%, and a simple transfusion of packed cells within an hour of presentation if the patient's hemoglobin is less than 10 g/dL. The patient then should have erythrocytapheresis or manual exchange to reduce the hemoglobin S percentage to below 30%. Computed tomography to exclude hemorrhage is mandatory and MR T2-weighted imaging with MRA, fat-saturated imaging of the neck (dissection), MR venography (sinovenous thrombosis), and diffusion-weighted imaging usually distinguishes between arterial ischemic stroke and the differential diagnoses. Comatose patients with widespread focal or global cerebral edema may have good functional outcome after surgical decompression. Anticoagulation may be indicated for dissection or sinovenous thrombosis and steroids for demyelination. Blood pressure should be reduced slowly if raised in patients with reversible posterior leukoencephalopathy. Seizures should be treated aggressively and electroencephalogram monitoring should be done to exclude subclinical seizures if the patient is unconscious. Hemorrhagic stroke may require craniectomy and drainage and/or management of vasospasm. Interventional neuroradiology with coils is an alternative to surgical clipping for aneurysms. For secondary prevention, regular blood transfusion to hemoglobin S of less than 30% reduces the risk of recurrent stroke from approximately 67% to approximately 10%. Hydroxyurea and phlebotomy may be used in patients who are alloimmunized. Moyamoya syndrome is a risk factor for recurrence despite prophylactic blood transfusion. Revascularization may prevent additional stroke. Bone marrow transplantation may be offered to patients with human leukocyte antigen-compatible siblings. Blood transfusion prevents stroke in patients with velocities greater than 200 cm per second on TCD; a phase III trial studying the prevention of the progression of silent infarction is being done. Emerging primary prophylaxis regimens being tested include citrulline and arginine, aspirin, and overnight oxygen supplementation. Physicians caring for children with sickle cell disease also should ensure adequate nutrition, including five servings of fruit and vegetables a day. The role of vitamin supplementation is controversial, particularly when patients must take daily penicillin prophylaxis.
Similar articles
- Big strokes in small persons.
Adams RJ. Adams RJ. Arch Neurol. 2007 Nov;64(11):1567-74. doi: 10.1001/archneur.64.11.1567. Arch Neurol. 2007. PMID: 17998439 Review. - Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
Higashida RT, Furlan AJ, Roberts H, Tomsick T, Connors B, Barr J, Dillon W, Warach S, Broderick J, Tilley B, Sacks D; Technology Assessment Committee of the American Society of Interventional and Therapeutic Neuroradiology; Technology Assessment Committee of the Society of Interventional Radiology. Higashida RT, et al. Stroke. 2003 Aug;34(8):e109-37. doi: 10.1161/01.STR.0000082721.62796.09. Epub 2003 Jul 17. Stroke. 2003. PMID: 12869717 - Stroke in Children.
Roach ES. Roach ES. Curr Treat Options Neurol. 2000 Jul;2(4):295-304. doi: 10.1007/s11940-000-0047-5. Curr Treat Options Neurol. 2000. PMID: 11096755 - Nocturnal hypoxaemia and central-nervous-system events in sickle-cell disease.
Kirkham FJ, Hewes DK, Prengler M, Wade A, Lane R, Evans JP. Kirkham FJ, et al. Lancet. 2001 May 26;357(9269):1656-9. doi: 10.1016/s0140-6736(00)04821-2. Lancet. 2001. PMID: 11425370 - Therapy insight: stroke risk and its management in patients with sickle cell disease.
Kirkham FJ. Kirkham FJ. Nat Clin Pract Neurol. 2007 May;3(5):264-78. doi: 10.1038/ncpneuro0495. Nat Clin Pract Neurol. 2007. PMID: 17479074 Review.
Cited by
- Moyamoya Biomarkers.
Smith ER. Smith ER. J Korean Neurosurg Soc. 2015 Jun;57(6):415-21. doi: 10.3340/jkns.2015.57.6.415. Epub 2015 Jun 30. J Korean Neurosurg Soc. 2015. PMID: 26180608 Free PMC article. Review. - Current therapy of sickle cell disease.
Aliyu ZY, Tumblin AR, Kato GJ. Aliyu ZY, et al. Haematologica. 2006 Jan;91(1):7-10. Haematologica. 2006. PMID: 16434364 Free PMC article. No abstract available. - Prevalence of Stroke in Asian Patients with Sickle Cell Anemia: A Systematic Review and Meta-Analysis.
Kuikel S, Rauniyar R, Kharel S, Bist A, Giri S, Thapaliya S, Paudel S. Kuikel S, et al. Neurol Res Int. 2021 Jun 3;2021:9961610. doi: 10.1155/2021/9961610. eCollection 2021. Neurol Res Int. 2021. PMID: 34150339 Free PMC article. Review. - Crises in Sickle Cell Disease.
Novelli EM, Gladwin MT. Novelli EM, et al. Chest. 2016 Apr;149(4):1082-93. doi: 10.1016/j.chest.2015.12.016. Epub 2015 Dec 28. Chest. 2016. PMID: 26836899 Free PMC article. Review. - Treatment and prevention of stroke in children with sickle cell disease.
Mehta SH, Adams RJ. Mehta SH, et al. Curr Treat Options Neurol. 2006 Nov;8(6):503-12. doi: 10.1007/s11940-006-0040-8. Curr Treat Options Neurol. 2006. PMID: 17032571
References
- Ann Fr Anesth Reanim. 1997;16(8):967-9 - PubMed
- J Pediatr Hematol Oncol. 2002 Oct;24(7):585-8 - PubMed
- J Pediatr. 1992 Jun;120(6):882-5 - PubMed
- Blood. 2000 May 15;95(10):3057-64 - PubMed
- Pediatr Neurol. 1995 Jan;12(1):77-80 - PubMed
LinkOut - more resources
Full Text Sources